Yes.
My subamendment also comes from testimony that we heard from Professor Herder. Basically what we're suggesting is that the requirements for disclosure need to be more targeted.
We would change this part of the amendment:
prescribed information concerning the clinical trial or investigational test is
It would instead read:the registration and results, whether positive or negative, from all clinical trials and other investigative tests be
And then it would continue on.
So we would change some of the wording in Mr. Young's amendment, beginning with the word “prescribed”.
I think we have something to hand out.... Oh, sorry; we don't.